Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Authors:
- 18 July 2007
- reference entry
- Published by Wiley
- No. 3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetesDiabetes & Vascular Disease Research, 2006
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006
- Initiating and maintaining physical activity for type 2 diabetes mellitus2004
- Meglitinide analogues for type 2 diabetes mellitus2003
- Composite Outcomes in Randomized TrialsJAMA, 2003
- The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes studyCommentary: UKPDS is well designed and clinically importantBMJ, 2001
- Lifestyle interventions for preventing type 2 diabetes mellitus2001
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960